Bjarnason I. , So A., Levi AJ, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs . Lancet. 1984;2 (8413):1171-1174.
2.
Bjarnason I. , Prouse P., Smith T., et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987;2 (8561):711-714.
3.
Bjarnason I. , Macpherson AJS.Intestinal toxicity of nonsteroidal anti-inflammatory drugs. Pharmacol Ther. 1994 ;62:145-147.
4.
Mahmud T., Scott DL, Bjarnason I.A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis. 1996;55:211-213.
5.
Sigthorsson G., Tibble J., Hayllar J., et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut. 1998;43:506-511.
6.
Smale S., Tibble J., Sigthorsson G., et al. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol. 2001;15:723-738.
7.
Thiefin G., Beaugerie L.Toxic effects of nonsteroidal anti-inflammatory drugs on the small bowel, colon and rectum. Joint Bone Spine. 2005;72:286-294.
8.
Kwo PY, Tremaine WJNonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc. 1995;70:55-61.
9.
Zein CO, Vandana N.40-year-old man with anemia, chronic low back pain and hypoalbuminemia . Mayo Clin Proc. 2001;76:1163-1166.
10.
Kamata Y., Iwamoto M., Nara H., et al. A case of rheumatoid arthritis with protein losing enteropathy induced by multiple diaphragmatic strictures of the small intestine: successful treatment by bougieing under double-balloon enteroscopy. Gut. 2005;55:1372.
11.
Tibble JA, Sigthorsson G., Foster R., et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999;45:362-366.
12.
Fortun PJ, Hawkey CJNonsteroidal anti-inflammatory drugs and the small intestine. Curr Opin Gastroenterol. 2005;21:169-175.
13.
Somasundaram S., Sigthorsson G., Simpson RJ, et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther. 2000;14: 639-650.
14.
Bjarnason I. , Zanelli G., Smith T., et al. Nonsteroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology. 1987;93:480-489.
15.
Meling TR, Aabakken L., Roseth A., et al. Faecal calprotectin shedding after short-term treatment with nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol . 1996;31:339-344.
16.
Morris AJ, Madhok R., Sturrock RD, Capell HA, MacKenzie JFEnteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet. 1991;337:520.
17.
Morris AJ, Wasson LA, MacKenzie JFSmall bowel enteroscopy in undiagnosed gastrointestinal blood loss . Gut. 1992;33:887-889.
18.
Lang J., Price AB, Levi AJ, Burke M., Gumpel JM, Bjarnason I.Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988;41:516-526.
19.
Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RIGastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749-754.
20.
Bjarnason I. , Hayllar J., Smethurst P., Price A., Gumpel MJMetronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy . Gut. 1992;33:1204-1208.
21.
Bjarnason I. , Smethurst P., Fenn CG, Lee CE, Menzies IS, Levi AJMisoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci. 1989;34:407-411.
22.
Bjarnason I. , Hopkinson N., Zanelli G., et al. Treatment of non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1990;31:777-780.
23.
Davies NM, Saleh JY, Skjodt NMDetection and prevention of NSAID-induced enteropathy. J Pharm Pharm Sci. 2000;3:137-155.
